CELL AND TISSUE SYSTEMS, INC.

Basic Information

2231 Technical Parkway, Suite A
NORTH CHARLESTON, SC, 29406-4931

Company Profile

n/a

Additional Details

Field Value
DUNS: 175100333
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Lessons from Nature: Antifreeze Glycolipids for Cryopreservation of Mammalian Cel

    Amount: $224,002.00

    DESCRIPTION (provided by applicant): Storage of cells for many researchers simply involves addition of 10% DMSO or similar cryoprotectants to cells in suspension, putting them in cryovials and slow co ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Cryopreservation of Engineered Tissue Equivalents

    Amount: $1,190,033.00

    ABSTRACT In an effort to reduce the use of animals for toxicity testing, companies have developed in vitro skin models or equivalents to replace the Draize skin irritation test. This development has b ...

    SBIR Phase II 2014 Department of Health and Human Services
  3. Cartilage storage solution for chondrocyte viability and biomaterial preservation

    Amount: $312,642.00

    DESCRIPTION (provided by applicant): Resurfacing of articular cartilage with cold stored osteochondral allografts is employed clinically for repair of trauma and osteoarthritis-induced articular carti ...

    SBIR Phase I 2013 Department of Health and Human Services
  4. hiPS Derived Cardiomyocyte Assay for Screening Toxicant Differentiation Effects

    Amount: $224,925.00

    ABSTRACT Obesity is a major global health issue. According to a recent report in the Journal of the American Medical Association non-Hispanic blacks have the highest age-adjusted rates of obesity (49. ...

    SBIR Phase I 2013 Department of Health and Human Services
  5. Non-Enzymatic Cryogenic Isolation of Therapeutic Cells

    Amount: $268,561.00

    DESCRIPTION (provided by applicant): In modern day medicine, cellular therapies, regenerative medicine and tissue engineering all involve technologies for harvesting, expanding, modifying and re-impla ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Feasibility of immunotherapy by ice-free cryopreservation of engineered human all

    Amount: $262,005.00

    DESCRIPTION (provided by applicant): Autologous regenerative medicine tissue therapy costs are very high because when individual tissues are manufactured all the costs fall on a single patient. Alloge ...

    SBIR Phase I 2012 Department of Health and Human Services
  7. Feasibibility of deep hypothermic (18-22C) perfusion storage of livers for transp

    Amount: $185,898.00

    DESCRIPTION (provided by applicant): More than 43,000 Americans die each year from liver disease, making it the 10th leading disease- related cause of death in the US. Cirrhosis with irreversible inju ...

    SBIR Phase I 2011 Department of Health and Human Services
  8. Pancreas perfusion with PFC-Unisol

    Amount: $312,027.00

    DESCRIPTION (provided by applicant): There is a worldwide consensus that islet transplantation may be considered a viable option for the treatment of insulin-dependent diabetes mellitus, and clinical ...

    SBIR Phase I 2011 Department of Health and Human Services
  9. Perfusion Device for Lung Evaluation and Transplantation

    Amount: $224,811.00

    DESCRIPTION (provided by applicant): Twenty four million Americans are affected with end-stage lung disease which is the 4th leading cause of death in the US, and there are currently 2,122 candidates ...

    SBIR Phase I 2011 Department of Health and Human Services
  10. Design and Assessment of a Compliant Nanofibrous Vascular Graft

    Amount: $278,179.00

    DESCRIPTION (provided by applicant): Vascular grafting is performed clinically to repair or replace diseased coronary artery and peripheral vessels to restore normal blood flow patterns. Synthetic gra ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government